Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00867477 | PMRR-NO: Pulmonary Metabolic Radiation Response Versus Exhaled Nitric Oxide | completed | Phase 2 | 163 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 28, 2014 | clinicaltrials |
| NCT01258192 | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients(nabPCESCC) | completed | Phase 2 | 35 | Zhejiang Cancer HospitalOTHER | 1 | Jul 29, 2014 | clinicaltrials |
| NCT01447927 | Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus | completed | Phase 2 | 93 | National Cancer Institute (NCI)NIH | 3 | Jul 21, 2014 | clinicaltrials |
| NCT02188615 | Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer(NACRFMIE) | unknown | Phase 2 | 120 | Chengchu ZhuOTHER | 1 | Jul 11, 2014 | clinicaltrials |
| NCT00474903 | Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus | completed | Phase 2 | 122 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2014 | clinicaltrials |
| NCT00004236 | Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00183807 | A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer | terminated | Phase 2 | 6 | University of Southern CaliforniaOTHER | 1 | May 22, 2014 | clinicaltrials |
| NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | completed | Phase 2 | 21 | Fox Chase Cancer CenterOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT01444547 | A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin | unknown | Phase 2 | 92 | Chinese Academy of Medical SciencesOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | unknown | Phase 1 / Phase 2 | 43 | Technical University of MunichOTHER | 1 | May 1, 2014 | clinicaltrials |
| NCT01843829 | A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer(NeoSCOPE) | unknown | Phase 2 | 85 | Lisette NixonOTHER_GOV | 1 | Mar 24, 2014 | clinicaltrials |
| NCT01256203 | Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light | withdrawn | Phase 2 | 0 | Pinnacle Biologics Inc.INDUSTRY | 0 | Mar 4, 2014 | clinicaltrials |
| NCT00903136 | Tethered Capsule Endoscope in Screening Participants for Barrett Esophagus | unknown | Phase 1 / Phase 2 | 50 | US Department of Veterans AffairsFED | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00281736 | Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer | completed | Phase 2 | 60 | Roswell Park Cancer InstituteOTHER | 1 | Jan 3, 2014 | clinicaltrials |
| NCT00005607 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | unknown | Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016274 | Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016287 | Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer | unknown | Phase 2 | 50 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00719550 | AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer | completed | Phase 1 / Phase 2 | 130 | AmgenINDUSTRY | 0 | Dec 5, 2013 | clinicaltrials |
| NCT00005876 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00470184 | Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer | completed | Phase 2 | 41 | Roswell Park Cancer InstituteOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01993784 | Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. | unknown | Phase 1 / Phase 2 | 9 | Peking UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT00636298 | Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy | withdrawn | Phase 2 | 0 | Emory UniversityOTHER | 0 | Nov 19, 2013 | clinicaltrials |
| NCT00258297 | Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery | terminated | Phase 2 | 30 | University of RochesterOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | completed | Phase 2 | 98 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00077545 | 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction | completed | Phase 2 | 39 | National Cancer Institute (NCI)NIH | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00002951 | Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | completed | Phase 2 | 53 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00003192 | Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | completed | Phase 2 | 15 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00971841 | Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 1 | Bristol-Myers SquibbINDUSTRY | 0 | Jul 26, 2013 | clinicaltrials |
| NCT00009880 | Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | completed | Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 1 | Jul 19, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00098527 | FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer | terminated | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00003087 | Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus | completed | Phase 2 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00006245 | Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00032123 | Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | completed | Phase 2 | — | SWOG Cancer Research NetworkNETWORK | 2 | Jun 24, 2013 | clinicaltrials |
| NCT00003055 | Cisplatin and Irinotecan in Treating Patients With Locally Advanced or Metastatic Esophageal or Gastric Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00005599 | Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00006038 | Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00016900 | PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00017056 | BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2013 | clinicaltrials |
| NCT00030862 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00045526 | Erlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer | completed | Phase 2 | 48 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00012246 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | terminated | Phase 2 | 7 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT01463501 | Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | unknown | Phase 1 / Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT01368419 | Continuous Endostar Infusion Combined With Radiotherapy in Esophageal Cancer Patients | unknown | Phase 2 | 40 | Jiangsu Simcere Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01271322 | Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)(HICON) | terminated | Phase 2 | — | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00017043 | BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy | completed | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | completed | Phase 2 | 50 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00004127 | Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 35 | University of ChicagoOTHER | 2 | Feb 11, 2013 | clinicaltrials |
| NCT00722605 | Multiple Respiration-Correlated Cone Beam Computed Tomography (CT) Scans to Reduce Target Positioning Errors in Radiotherapy Treatment of Thoracic Cancer | completed | Phase 1 / Phase 2 | 16 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 24, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 28, 2014source: clinicaltrials